6 results about "Sugar absorption" patented technology

The invention discloses a mulberry leaf fermentation composition helpful for reversing insulin resistance and a preparation method thereof, relates to the technical field of mulberry leaf fermentation treatment, and solves the problem that in the prior art, a technology for preparing auxiliary materials for assisting diabetes treatment from mulberry leaves and related products do not exist. The mulberry leaf fermentation composition is prepared from a mulberry leaf extract, a highland barley extract, a bitter gourd extract, hawthorn powder, yam flour, lemon powder, fructo-oligosaccharide, water-soluble dietary fibers, resistant dextrin and a fermentation microbial preparation, wherein the highland barley extract is prepared by mixing a highland barley flavone extract and a highland barley polysaccharide extract according to a mass ratio of (4-6): 1. Through multi-channel combination of'inhibiting sugar absorption, enhancing insulin signals, protecting islet cells and improving metabolism ', insulin signal channels can be effectively improved, inflammatory oxidative stress can be relieved, glucose and lipid metabolism disorder can be regulated, and insulin resistance can be reversed.

The invention relates to the field of functional foods, and discloses a preparation method of a composition for assisting in reducing blood sugar of diabetes based on shiny-leaved yellowhorn leaves. The composition comprises the following components in percentage by mass: 2.00% of rutin, 1.00% of ursolic acid, 3.00% of charantin, 0.05% of chromium picolinate, 2.00% of a mulberry leaf extract, 2.00% of puerarin, 8.00% of an astragalus membranaceus extract, 10.00% of Chinese yam powder, 2.00% of a ginseng extract, 20.00% of oligosaccharide, 48.45% of soluble dietary fibers, 1.00% of erythritol and 0.50% of microcrystalline cellulose. The Xanthoceras sorbifolia leaf double-component extraction is adopted, multiple natural functional factors and a low-GI matrix are matched, and the effect of assisting in reducing blood sugar is achieved through multi-channel synergy of regulating intestinal flora, delaying sugar absorption, enhancing insulin sensitivity and the like. The composition has the advantages of high safety and natural components, can be industrially granulated and produced, and is suitable for auxiliary conditioning of prediabetic people and patients with type 2 diabetes mellitus. The invention also discloses a preparation method and action verification data of the composition.

The invention relates to the technical field of special diet food and diabetes nutrition support, and discloses low-GI diabetes special nutrition formula powder which is prepared from the following components in parts by weight: 22-36 parts of buckwheat, 3-18 parts of yellow millet, 1-5 parts of quinoa flour, 1-6 parts of konjak, 1-6 parts of resistant starch, 1-6 parts of soybean protein isolate, 6-10 parts of wheat germ and 3-8 parts of phaseolus calcaratus. The special nutritional formula powder for the low-GI diabetes mellitus is prepared by compounding low-GI whole grains and medicinal and edible raw materials, so that sugar absorption can be delayed, postprandial blood sugar can be stabilized, sudden rising of the blood sugar can be avoided from the source, and the metabolic requirements of patients can be met. The formula is balanced in nutrition, can supplement high-quality protein, dietary fibers and trace elements, improves nutritional imbalance, is optimized by a process, is good in solubility and fine and smooth in taste, solves the problem of poor eating compliance, and is stable to store. The formula has nutrition and conditioning effects, can improve insulin sensitivity, and provides special support for both sugar control and nutrition for diabetics.

The application discloses a surface-engineered Gouqi-source exosome ophthalmic preparation for treating ocular surface diseases, and belongs to the technical field of ocular surface drug delivery and plant-source exosome preparation. The preparation takes Gouqi-source exosomes as the main body, takes a mucin-related peptide-anchor molecule complex capable of combining with, adsorbing, intertwining or anchoring the ocular mucosa, epithelial sugar absorption or mucin network, and having an ocular surface repair effect as a surface modification unit, and is used for improving the residence capacity of the exosomes on the ocular surface and enhancing the ocular surface repair effect.

This invention discloses a food formula for stabilizing blood sugar in diabetic patients, belonging to the field of functional foods and fermentation engineering technology. The formula consists of the following ingredients in parts by weight: 15-25 parts of purple wheat bran (No. 2), 5-10 parts of soybean flour, 5-10 parts of black soybean flour, 5-10 parts of peanut flour, 10-15 parts of walnut kernel flour, 10-20 parts of purple jujube powder, 0.5-2 parts of Haematococcus pluvialis astaxanthin microcapsule powder, 0.3-1.5 parts of lutein ester microcapsule powder, 2-5 parts of *Lactobacillus plantarum* post-biotic powder, 3-8 parts of psyllium husk powder, 3-8 parts of resistant dextrin, 0.3-1 part of chromium-enriched yeast powder, 2-6 parts of pumpkin powder, 1-4 parts of shiitake mushroom powder, and 3-8 parts of purple onion powder. This invention's formula synergistically intervenes in blood sugar metabolism through multiple pathways, including protecting pancreatic β-cells, regulating intestinal flora, alleviating oxidative stress, and delaying sugar absorption. It is safe for long-term consumption without side effects, providing diabetic patients with a dietary option to help stabilize blood sugar.

The present invention relates to a composition for the prevention, improvement, or treatment of obesity or obesity-induced inflammation comprising patulin as an active ingredient. A composition containing patulin as an active ingredient according to the present invention has the effect of inhibiting lipid accumulation, and can inhibit lipid accumulation by regulating sugar absorption, glycerol excretion, or LDL absorption, reducing the expression of factors related to lipogenesis or lipid synthesis such as Pparγ, Fasn, Acly, C / ebpα, Fabp4, Cd36, Dgat2, or Gpat, increasing the expression of fatty acid oxidation regulators such as PGC1α or CPT1a, and improving the volume and membrane potential of mitochondria. In addition, it can inhibit the expression of pro-inflammatory cytokines or inflammatory regulators such as IL-6, TNF-α, iNOS, or Cox-2, thereby preventing, treating, or improving obesity or obesity-induced inflammation, and can be utilized as a material for food, feed, pharmaceuticals, quasi-pharmaceuticals, etc.